Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Lower SMAD2/3 activation predicts more severe skin cancer.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Alopecia areata involves specific immune cells, offering potential treatment targets.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

CD44 signaling can help heal wounds without scars.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

CD28 is a promising target for treating alopecia areata with belatacept.